Cargando…

Botulinum toxin in the treatment of Raynaud phenomenon in patients with systemic sclerosis: a systemic review

Detalles Bibliográficos
Autores principales:	Cai, Ruyi, Yi, Zixi, Li, Ting, Mu, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276337/ https://www.ncbi.nlm.nih.gov/pubmed/35773968 http://dx.doi.org/10.1097/CM9.0000000000001903

Ejemplares similares

Botulinum toxin A in the treatment of Raynaud's phenomenon: a systematic review
por: Żebryk, Paweł, et al.
Publicado: (2015)

Efficacy of botulinum toxin type A injection for Raynaud’s phenomenon and digital ulcers in patients with systemic sclerosis
por: Jokar, Mohammad Hassan, et al.
Publicado: (2022)

Audiovestibular Manifestations in Patients with Primary Raynaud’s Phenomenon and Raynaud’s Phenomenon Secondary to Systemic Sclerosis
por: Amor-Dorado, Juan Carlos, et al.
Publicado: (2023)

Raynaud’s Phenomenon with Focus on Systemic Sclerosis
por: Maciejewska, Magdalena, et al.
Publicado: (2022)

Use of Botulinum Toxin A to Treat Chemotherapy-Induced Raynaud’s Phenomenon
por: Potluri, Thrisha K, et al.
Publicado: (2021)

Improvement of pterygium inversum unguis and Raynaud phenomenon with interdigital botulinum toxin injections
por: Kim, Daniel J., et al.
Publicado: (2022)

Hyperspectral imaging in systemic sclerosis-associated Raynaud phenomenon
por: Teaw, Shannon, et al.
Publicado: (2023)

Botulinum toxin type A in the treatment of Raynaud’s phenomenon: A three-year follow-up study
por: Medina, Susana, et al.
Publicado: (2018)

Reduced levels of S-nitrosothiols in plasma of patients with systemic sclerosis and Raynaud's phenomenon
por: Kundu, Devi, et al.
Publicado: (2014)

Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis
por: Arefiev, Kait, et al.
Publicado: (2011)

Rheopheresis for Digital Ulcers and Raynaud's Phenomenon in Systemic Sclerosis Refractory to Conventional Treatments
por: Korsten, Peter, et al.
Publicado: (2019)

Systemic lupus erythematosus and Raynaud's phenomenon
por: Heimovski, Flavia Emilie, et al.
Publicado: (2015)

Raynaud’s phenomenon
por: Solomons, HD
Publicado: (2011)

Raynaud's Phenomenon
por: Shah, Jehan, et al.
Publicado: (2013)

A case report of the beneficial effects of botulinum toxin type A on Raynaud phenomenon in a patient with lung cancer
por: Wang, Lu, et al.
Publicado: (2016)

Advances in the treatment of Raynaud’s phenomenon
por: Levien, Terri L
Publicado: (2010)

Application of the 2013 ACR/EULAR classification criteria for systemic sclerosis to patients with Raynaud’s phenomenon
por: Park, Jin-Su, et al.
Publicado: (2015)

Artifactual Hypoglycaemia in Systemic Sclerosis and Raynaud's Phenomenon: A Clinical Case Report and Short Review
por: Bishay, RH, et al.
Publicado: (2016)

Botulinum Toxin A for Treatment of Diaphragmatic Myoclonus
por: He, Yi-Jing, et al.
Publicado: (2017)

Raynaud’s phenomenon in childhood-onset systemic lupus erythematous
por: Jiang, Qi, et al.
Publicado: (2022)

Abstract 95: The Use of Ultrasound Guidance for the treatment of Raynaud’s Disease of the Hand with Botulinum Toxin
por: Lobb, David C., et al.
Publicado: (2019)

Association between systemic sclerosis, palmar fasciitis with polyarthritis, Raynaud’s phenomenon and erythromelalgia with underlying malignancy
por: Nowak, Katarzyna, et al.
Publicado: (2022)

Raynaud's phenomenon in pediatric age
por: Tavares, M, et al.
Publicado: (2011)

Raynaud's Phenomenon: Beware of Cancers!
por: Aqodad, Zahida, et al.
Publicado: (2021)

Solvent-Induced Raynaud’s Phenomenon
por: Rodrigues, Helena, et al.
Publicado: (2023)

The frequency of Raynaud’s phenomenon, very early diagnosis of systemic sclerosis, and systemic sclerosis in a large Veteran Health Administration database
por: Frech, Tracy M., et al.
Publicado: (2021)

Progressive Systemic Sclerosis With Negative Antinuclear Antibodies and Absence of Raynaud’s Phenomenon: A Case Report and Literature Review
por: Falls, Anna C, et al.
Publicado: (2023)

Pulmonary capillary hemangiomatosis or hepatopulmonary syndrome in a patient with calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly and telangiectasia syndrome?
por: Shrestha, Bijaya Laxmi, et al.
Publicado: (2020)

The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud’s Phenomenon: A Case Series
por: Winter, Amelia R, et al.
Publicado: (2020)

Raynaud’s Phenomenon: Reviewing the Pathophysiology and Management Strategies
por: Nawaz, Iqra, et al.
Publicado: (2022)

The Relationship between Smoking, Raynaud's Phenomenon, Digital Ulcers, and Skin Thickness in the Waikato Systemic Sclerosis Cohort
por: Silva, Cherumi, et al.
Publicado: (2022)

The mechanism of botulinum A on Raynaud syndrome
por: Zhou, Yanwen, et al.
Publicado: (2018)

Recent achievements in the management of Raynaud’s phenomenon
por: Baumhäkel, Magnus, et al.
Publicado: (2010)

Glomus Tumor Presenting as Raynaud's Phenomenon
por: Abdelrahman, M. H., et al.
Publicado: (2012)

Monostotic fibrous dysplasia with Raynaud's phenomenon
por: Kumar, K. V. S. Hari, et al.
Publicado: (2015)

Pacinian hyperplasia presenting with Raynaud’s phenomenon
por: Pickrell, Brent B., et al.
Publicado: (2019)

Prevalence of Raynaud’s Phenomenon in Saudi Arabia
por: Mustafa, Mohammad, et al.
Publicado: (2022)

Lower limb ulcer and Raynaud's phenomenon
por: Chérif, Mohammad Yassine, et al.
Publicado: (2022)

Raynaud’s Phenomenon: A Brush Up!
por: Swarnkar, Bhavya, et al.
Publicado: (2023)

A violist with asymmetrical Raynaud’s phenomenon
por: Silva, Beatriz C, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_volqosdq9ochohprtm35846o07